Biblio

Found 1149 results
Filters: Filter is   [Clear All Filters]
2013
Griffis CA, Breen ECrabb, Compton P, Goldberg A, Witarama T, Kotlerman J, Irwin MR.  2013.  Acute painful stress and inflammatory mediator production.. Neuroimmunomodulation. 20(3):127-33.
Halpin LE, Northrop NA, Yamamoto BK.  2013.  Ammonia Mediates Methamphetamine-Induced Increases in Glutamate and Excitotoxicity. Neuropsychopharmacology. 39:1031–1038.
Pomykala KL, Ganz PA, Bower JE, Kwan L, Castellon SA, Mallam S, Cheng I, Ahn R, Breen EC, Irwin MR et al..  2013.  The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer.. Brain Imaging Behav. 7(4):511-23.
Cho HJ, Kivimäki M, Bower JE, Irwin MR.  2013.  Association of C-reactive protein and interleukin-6 with new-onset fatigue in the Whitehall II prospective cohort study.. Psychol Med. 43:1773-83.
Cho HJ, Kivimäki M, Bower JE, Irwin MR.  2013.  Association of C-reactive protein and interleukin-6 with new-onset fatigue in the Whitehall II prospective cohort study.. Psychol Med. 43(8):1773-83.
Masten CL, Eisenberger NI, Pfeifer JH, Colich NL, Dapretto M.  2013.  Associations among pubertal development, empathic ability, and neural responses while witnessing peer rejection in adolescence.. Child Dev. 84(4):1338-54.
Ventura EE, Ganz PA, Bower JE, Abascal L, Petersen L, Stanton AL, Crespi CM.  2013.  Barriers to physical activity and healthy eating in young breast cancer survivors: modifiable risk factors and associations with body mass index.. Breast Cancer Res Treat. 142(2):423-33.
Moreno-Smith M, Lee SJoo, Lu C, Nagaraja AS, He G, Rupaimoole R, Han HDong, Jennings NB, Roh J-W, Nishimura M et al..  2013.  Biologic effects of dopamine on tumor vasculature in ovarian carcinoma.. Neoplasia. 15(5):502-10.
Chai MG, Kim-Fuchs C, Angst E, Sloan EK.  2013.  Bioluminescent orthotopic model of pancreatic cancer progression.. J Vis Exp. (76)
Zanello A, Berthoud L, Ventura J, Merlo MCG.  2013.  The Brief Psychiatric Rating Scale (version 4.0) factorial structure and its sensitivity in the treatment of outpatients with unipolar depression. Psychiatry Research. 210:626–633.
Marcus AC, Diefenbach MA, Stanton AL, Miller SM, Fleisher L, Raich PC, Morra ME, Perocchia RSlevin, Tran ZVu, Bright MAnne.  2013.  Cancer patient and survivor research from the cancer information service research consortium: a preview of three large randomized trials and initial lessons learned.. J Health Commun. 18(5):543-62.
Hoyt MA, Stanton AL, Irwin MR, Thomas KMS.  2013.  Cancer-related masculine threat, emotional approach coping, and physical functioning following treatment for prostate cancer.. Health Psychol. 32(1):66-74.
O'Connor M-F, M Shear K, Fox R, Skritskaya N, Campbell B, Ghesquiere A, Glickman K.  2013.  Catecholamine predictors of complicated grief treatment outcomes.. Int J Psychophysiol. 88(3):349-52.
Christie KM, Meyerowitz BE, Stanton AL, Rowland JH, Ganz PA.  2013.  Characteristics of breast cancer survivors that predict partners' participation in research.. Ann Behav Med. 46(1):107-13.
Carroll JE, Gruenewald TL, Taylor SE, Janicki-Deverts D, Matthews KA, Seeman TE.  2013.  Childhood abuse, parental warmth, and adult multisystem biological risk in the Coronary Artery Risk Development in Young Adults study.. Proc Natl Acad Sci U S A. 110(42):17149-53.
Youngstedt SD, Jean-Louis G, Bootzin RR, Kripke DF, Cooper J, Dean LR, Catao F, James S, Vining C, Williams NJ et al..  2013.  Chronic moderate sleep restriction in older long sleepers and older average duration sleepers: a randomized controlled trial.. Contemp Clin Trials. 36(1):175-86.
Ganz PA, Kwan L, Castellon SA, Oppenheim A, Bower JE, Silverman DHS, Cole SW, Irwin MR, Ancoli-Israel S, Belin TR.  2013.  Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.. J Natl Cancer Inst. 105(11):791-801.
Nicassio PM, Draper TL, Ormseth SR.  2013.  Conceptualizing and examining the role of stress in arthritis: a comment on Harris et al.. Ann Behav Med. 46(1):1-2.
Schrepf A, Clevenger L, Christensen D, DeGeest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L, Penedo F, Lucci JA et al..  2013.  Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability.. Brain Behav Immun. 30 Suppl:S126-34.
Khalsa S.  2013.  Current Diagnosis and Treatment of Anxiety Disorders. Pharmacy and Therapeutics. 38:30-57.
Bower JE, Ganz PA, Irwin MR, Castellon S, Arevalo J, Cole SW.  2013.  Cytokine genetic variations and fatigue among patients with breast cancer.. J Clin Oncol. 31(13):1656-61.
Irwin MR.  2013.  Depression and insomnia in cancer: prevalence, risk factors, and effects on cancer outcomes.. Curr Psychiatry Rep. 15(11):404.
Ganz PA, Bower JE, Kwan L, Castellon SA, Silverman DHS, Geist C, Breen EC, Irwin MR, Cole SW.  2013.  Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction? Brain Behav Immun. 30 Suppl:S99-108.
Jarcho MR, Slavich GM, Tylova-Stein H, Wolkowitz OM, Burke HM.  2013.  Dysregulated diurnal cortisol pattern is associated with glucocorticoid resistance in women with major depressive disorder.. Biol Psychol. 93(1):150-8.
Doering LV, Chen B, Bodán RCross, Magsarili MC, Nyamathi A, Irwin MR.  2013.  Early cognitive behavioral therapy for depression after cardiac surgery.. J Cardiovasc Nurs. 28(4):370-9.

Pages